WallStreetZenWallStreetZen

NYSE: MED
Medifast Inc Stock

Overview
ForecastEarningsDividendOwnership
$32.60+0.16 (+0.49%)
Updated Apr 22, 2024
MED Price
$32.60
Fair Value Price
N/A
Market Cap
$355.20M
52 Week Low
$30.95
52 Week High
$109.52
P/E
3.57x
P/B
1.76x
P/S
0.68x
PEG
0.34x
Dividend Yield
10.12%
Revenue
$1.07B
Earnings
$99.42M
Gross Margin
72.4%
Operating Margin
11.78%
Profit Margin
9.3%
Debt to Equity
0.54
Operating Cash Flow
$148M
Beta
0.98
Next Earnings
Apr 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A

MED Overview

Medifast Incorporated manufactures weight loss, weight management, healthy living products, and other consumable health and nutritional products. Offerings include bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. Medifast was founded in 1980 and is headquartered in Baltimore, MD.

Zen Score

–
Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MED scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MED ($32.60) is trading below its intrinsic value of $83.54, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MED is good value based on its earnings relative to its share price (3.57x), compared to the US market average (41x)
P/E vs Market Valuation
MED is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more MED due diligence checks available for Premium users.

Be the first to know about important MED news, forecast changes, insider trades & much more!

MED News

Valuation

MED price to earnings (PE)

For valuing profitable companies with steady earnings
Company
3.57x
Industry
38.02x
Market
41x
MED is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MED is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

MED price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.76x
Industry
11.45x
MED is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MED price to earnings growth (PEG)

For valuing profitable companies with growth potential
MED is good value based... subscribe to Premium to read more.
PEG Value Valuation

MED's financial health

Profit margin

Revenue
$191.0M
Net Income
$6.0M
Profit Margin
3.2%
MED's Earnings (EBIT) of $126.31M... subscribe to Premium to read more.
Interest Coverage Financials
MED's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$309.9M
Liabilities
$108.4M
Debt to equity
0.54
MED's short-term assets ($224.03M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MED's short-term assets ($224.03M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MED's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
MED's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$10.5M
Investing
-$10.7M
Financing
-$17.9M
MED's operating cash flow ($147.66M)... subscribe to Premium to read more.
Debt Coverage Financials

MED vs Personal Service Stocks

TickerMarket Cap1d %P/EP/B
MED$355.20M+0.49%3.57x1.76x
CSV$377.48M+3.88%11.13x2.18x
EM$167.64M+0.78%13.72x0.44x
WW$129.10M-4.68%-1.12x-0.17x
MRM$29.59M-0.33%-0.12x-10.12x
View Top Personal Service Stocks

Medifast Stock FAQ

What is Medifast's quote symbol?

(NYSE: MED) Medifast trades on the NYSE under the ticker symbol MED. Medifast stock quotes can also be displayed as NYSE: MED.

If you're new to stock investing, here's how to buy Medifast stock.

What is the 52 week high and low for Medifast (NYSE: MED)?

(NYSE: MED) Medifast's 52-week high was $109.52, and its 52-week low was $30.95. It is currently -70.23% from its 52-week high and 5.33% from its 52-week low.

How much is Medifast stock worth today?

(NYSE: MED) Medifast currently has 10,895,595 outstanding shares. With Medifast stock trading at $32.60 per share, the total value of Medifast stock (market capitalization) is $355.20M.

Medifast stock was originally listed at a price of $1.44 in Dec 31, 1997. If you had invested in Medifast stock at $1.44, your return over the last 26 years would have been 2,167.04%, for an annualized return of 12.75% (not including any dividends or dividend reinvestments).

How much is Medifast's stock price per share?

(NYSE: MED) Medifast stock price per share is $32.60 today (as of Apr 22, 2024).

What is Medifast's Market Cap?

(NYSE: MED) Medifast's market cap is $355.20M, as of Apr 23, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Medifast's market cap is calculated by multiplying MED's current stock price of $32.60 by MED's total outstanding shares of 10,895,595.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.